EQIX vs MREO · P/E 79, rev $5.07B vs $48.7M cap
Equinix Inc (EQIX) versus Mereo BioPharma Group PLC ADR (MREO) — a side-by-side from cached financials, not a winner call.
Equinix Inc (EQIX) is a reit - specialty company listed on US.
Mereo BioPharma Group PLC ADR (MREO) is a biotechnology company listed on US.
Latest reported EQIX revenue for 2026-06-30 was $5.07B. Net income was $894.0M. EQIX currently screens at market cap $74.23B and trailing P/E 79.4.
Latest reported MREO revenue for 2026-06-30 was $0. Net income was -$7.0M. Revenue was down 100.0% from 2026-03-31 to 2026-06-30. MREO currently screens at market cap $48.7M.
EQIX currently screens at market cap $74.23B and trailing P/E 79.4. MREO currently screens at market cap $48.7M.
Not investment advice. Open the EQIX and MREO stock pages for the full models.
Not investment advice.